A detailed history of Versant Capital Management, Inc transactions in Natera, Inc. stock. As of the latest transaction made, Versant Capital Management, Inc holds 48 shares of NTRA stock, worth $7,253. This represents 0.0% of its overall portfolio holdings.

Number of Shares
48
Previous 76 36.84%
Holding current value
$7,253
Previous $8,000 25.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

SELL
$97.75 - $129.67 $2,737 - $3,630
-28 Reduced 36.84%
48 $6,000
Q2 2024

Jul 05, 2024

BUY
$85.28 - $112.6 $6,481 - $8,557
76 New
76 $8,000
Q2 2023

Jul 10, 2023

BUY
$47.08 - $55.16 $141 - $165
3 New
3 $0

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $14.7B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Versant Capital Management, Inc Portfolio

Follow Versant Capital Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Versant Capital Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Versant Capital Management, Inc with notifications on news.